Thus, bone resorption and bone remodelling accelerate as ovarian function declines; the increased action of RANKL results in a longer lifespan of osteoclasts and increased rate of bone remodelling in postmenopausal osteoporosis (25,26). The gene discussed is TNFSF11; the disease is postmenopausal osteoporosis.